Actively Recruiting
Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension
Led by Necmettin Erbakan University · Updated on 2026-03-24
500
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective single-center observational study aims to evaluate the relationship between elevated plasma homocysteine levels and early echocardiographic abnormalities in patients with newly diagnosed essential hypertension. Adult patients diagnosed with essential hypertension within the previous 6 months will undergo clinical assessment, ambulatory blood pressure monitoring, electrocardiography, laboratory testing, and comprehensive transthoracic echocardiography including diastolic function assessment and strain analysis when image quality is adequate. Participants will be classified according to plasma homocysteine level using, and patients with elevated and normal homocysteine levels will be compared with respect to diastolic dysfunction and left ventricular and left atrial global longitudinal strain parameters. Clinical, laboratory, and echocardiographic data will also be used to develop a machine-learning based model for prediction of H-type hypertension.
CONDITIONS
Official Title
Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Newly diagnosed essential hypertension within the previous 6 months
- Ability and willingness to provide informed consent
- Availability for clinical evaluation, laboratory testing, ambulatory blood pressure monitoring, electrocardiography, and transthoracic echocardiography
You will not qualify if you...
- Resistant hypertension
- Secondary hypertension
- Acute coronary syndrome within the previous 6 months
- Major surgery within the previous 6 months
- Known heart failure
- Pulmonary hypertension
- Congenital heart disease
- Atrial fibrillation or atrial flutter
- Moderate or severe valvular heart disease
- Chronic kidney disease
- Anemia
- Current folate, vitamin B12, or vitamin B6 supplementation or treatment
- Inadequate echocardiographic image quality for strain analysis
- Known systemic conditions that may significantly affect plasma homocysteine levels
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Necmettin Erbakan University Meram Faculty of Medicine
Konya, Meram, Turkey (Türkiye), 42080
Actively Recruiting
Research Team
Y
yunus emre yavuz, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here